Aviso: para depositar documentos, por favor, inicia sesión e identifícate con tu cuenta de correo institucional de la UCM con el botón MI CUENTA UCM. No emplees la opción AUTENTICACIÓN CON CONTRASEÑA
 

Effect of Roux-en-Y gastric surgery on ciprofloxacin pharmacokinetics: an obvious effect?

dc.contributor.authorRivas Paterna, Ana Belén
dc.contributor.authorLopez Picado, Amanda
dc.contributor.authorSalas Bruton, Maria del Rosario
dc.contributor.authorTerleira Fernández, Ana Isabel
dc.contributor.authorSánchez Pernaute, Andrés
dc.contributor.authorTorres García, Antonio José
dc.contributor.authorMoreno Lopera, Carmen
dc.contributor.authorChicharro, Luis Miguel
dc.contributor.authorBandrés Moya, Fernando
dc.contributor.authorRubio Herrera, Miguel Ángel
dc.contributor.authorPortolés Pérez, Antonio
dc.contributor.authorVargas Castrillón, Emilio
dc.date.accessioned2025-01-30T19:57:35Z
dc.date.available2025-01-30T19:57:35Z
dc.date.issued2019-01-16
dc.description.abstractPurpose To evaluate pharmacokinetic parameters of ciprofloxacin in patients undergoing Roux-en-Y gastric surgery (RYGS). Methods Controlled, single-dose, open-label study in patients undergoing RYGS. Healthy overweight/obese patients 18–60 years old were included. The assessment was performed once in control patients and three times in case patients (before surgery and 1 and 6 months after surgery). In each visit, the subjects received a single oral dose of ciprofloxacin 500 mg. Venous blood samples were obtained at baseline and 0.5, 1, 1.25, 1.5, 1.75, 2, 2.5, 3, 4, 8 and 14 h after ciprofloxacin intake. Pre- and post-surgery variables were compared using paired ANOVA or the Wilcoxon tests and control vs cases using ANOVA or Mann Whitney. Given the post-surgery change in body weight, the parameters were corrected by dose (mg)/body weight (kg). The analysis was performed using SPSS. Results Ciprofloxacin Cmax was significantly reduced 1 month after surgery (1840.9 ± 485.2 vs 1589.6 ± 321.8 ng/ml; p = 0.032) but not 6 months after. Cmax on the sixth month was lower than Cmax in control group (2160.4 ± 408.6 vs 1589.6 ± 321.8 ng/ml; p < 0.001). After correcting by the dose (mg)/patient’s body weight, both Cmax and AUClast showed significant decrease 1 and 6 months after surgery: Cmax, 289.1 ± 65.3 and 263.5 ± 52.1 (ng/ml)/(dose (mg)/weight (kg)) respectively vs 429.3 ± 127.6 (ng/ml)/(dose (mg)/weight (kg)) at baseline; AUC, 1340.6 ± 243.0 and 1299.2 ± 415.4 (h × ng/ml)/(dose (mg)/weight (kg)) respectively vs 1896.7 ± 396.8 (h × ng/ml)/(dose (mg)/weight (kg)) at baseline. Cmax 1 month post-surgery showed lower values than the control group (375.4 ± 77.4 vs 263.5 ± 52.1 ng/ml; p < 0.001). Conclusion Ciprofloxacin absorption is impaired 1 month and 6 months after RYGS. The effect on Cmax and AUClast faded on the sixth month due to weight loss. It is no necessary to modify the doses of ciprofloxacin in these patients.
dc.description.departmentDepto. de Enfermería
dc.description.facultyFac. de Enfermería, Fisioterapia y Podología
dc.description.refereedTRUE
dc.description.sponsorshipISCIII
dc.description.statuspub
dc.identifier.citationRivas, A.B., Lopez-Picado, A., Salas-Butrón, M.d. et al. Effect of Roux-en-Y gastric surgery on ciprofloxacin pharmacokinetics: an obvious effect?. Eur J Clin Pharmacol 75, 647–654 (2019). https://doi.org/10.1007/s00228-018-02623-8
dc.identifier.doi10.1007/s00228-018-02623-8
dc.identifier.essn0031-6970
dc.identifier.issn0031-6970
dc.identifier.officialurlhttps://doi.org/10.1007/s00228-018-02623-8
dc.identifier.relatedurlhttps://link.springer.com/article/10.1007/s00228-018-02623-8
dc.identifier.urihttps://hdl.handle.net/20.500.14352/117478
dc.journal.titleEuropean Journal of Clinical Pharmacology
dc.language.isoeng
dc.page.final654
dc.page.initial647
dc.publisherSpringer Nature
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.accessRightsrestricted access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.cdu61
dc.subject.keywordBioavailability
dc.subject.keywordPharmacokinetic-pharmacodynamic
dc.subject.keywordSurgery Antibiotics
dc.subject.keywordObesity
dc.subject.ucmCiencias Biomédicas
dc.subject.unesco32 Ciencias Médicas
dc.titleEffect of Roux-en-Y gastric surgery on ciprofloxacin pharmacokinetics: an obvious effect?
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number75
dspace.entity.typePublication
relation.isAuthorOfPublication159fe910-2195-4873-b674-5bbd5c63885d
relation.isAuthorOfPublicationb0397877-9b69-4fd4-b046-f5c27b2d57e3
relation.isAuthorOfPublication64ea548c-394b-4f2a-aeaa-2341b7416dc1
relation.isAuthorOfPublication790390e8-2a0b-4dca-9996-3e85d11acad7
relation.isAuthorOfPublicationca835f2e-49b1-4f9e-ba37-3d10539e0cd8
relation.isAuthorOfPublication54bfb565-4a99-41ce-a708-42a43080f9a3
relation.isAuthorOfPublicatione300f851-eae0-41ad-b02a-9bb12d58f55d
relation.isAuthorOfPublicationfe8488c9-3dbf-457f-9478-4b50f697f714
relation.isAuthorOfPublication.latestForDiscovery159fe910-2195-4873-b674-5bbd5c63885d

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Effect_of_Roux_en_Y_gastric.pdf
Size:
792.65 KB
Format:
Adobe Portable Document Format

Collections